Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 1 recruiting now early-phase tilt small index

Cocaine Abuse: early-phase trial registry

1 of 10 indexed Cocaine Abuse trials are currently recruiting, with more weight in Phase 1-2.

Corpus placement: #1,724 of 28,707 conditions by registered trial count.

10 US clinical trials · 1 currently recruiting · #1,724 of 28,707 conditions by registered trial count

Cocaine Abuse: 10 US clinical trials tracked, 1 recruiting.

Cocaine Abuse is the subject of 10 registered US clinical trials on ClinicalTrials.gov, 1 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 7 in Phase 1-2 (earlier-stage). The most active sponsor is Baylor College of Medicine, running 2 of these trials.

Enrollment posture brief

Registry condition cocaine-abuse

OPEN 1 | RECR 10% | LATE 0 | EARLY 7 | RANK #1724 | SPON 2

Nearest open-share peer: Angina Pectoris (10% recruiting · 10 trials)

Acute Leukemia of Ambiguous 80%Achondroplasia40%Accelerated Phase Chronic My20%Accidental Fall20%Cocaine Abuse (this)10%
Open-enrollment share among volume-matched conditions near Cocaine Abuse

Cocaine Abuse lists 1 open slots (10% of 10 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Cocaine Abuse on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Cocaine Abuse is recruiting below its size-band peers.

    1 of 10 indexed trials (10%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Cocaine Abuse research.

    Baylor College of Medicine accounts for 2 of 10 trials (20%). 8 distinct sponsors appear on at least one study for this condition label.

  3. Most Cocaine Abuse trials plan to enrol fewer than 100 people.

    Median target enrolment is 96 among the 10 trials that report a genuine target (sentinel values excluded). 6 of those (60%) plan for fewer than 100 participants.

  4. Cocaine Abuse research is mostly interventional.

    9 interventional and 1 observational studies make up this index (90% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase 15Phase 22

Phase Distribution

PhaseTrial count
Phase 1 5
Phase 2 2

Named interventions

Most-linked intervention names on Cocaine Abuse records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Placebo Drug
4 trials
n-Acetylcysteine Drug
1 trials
Huperzine A 0.8 mg Drug
1 trials
Rivastigmine 6 mg Drug
1 trials
Huperzine A 0.4 mg Drug
1 trials
Rivastigmine 3 mg Drug
1 trials
Disulfiram plus Contingency Management Drug
1 trials
Placebo plus Contingency Management Behavioral
1 trials

US sites by state

Facility locations filed on Cocaine Abuse trials. A trial with sites in several states counts in each.

Texas 3 trials
Connecticut 2 trials
Pennsylvania 1 trials
New York 1 trials
Minnesota 1 trials
Kentucky 1 trials
Kansas 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

What to do with this Cocaine Abuse page

10 registered trials, 1 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Cocaine Abuse condition card totals 10 registered trials; most-linked intervention Placebo; top US site state Texas. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.